Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.63 |
| ▸ | PPARA | Q07869 | 1/20 | 0.63 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.61 |
| ▸ | TPH1 | P17752 | 5/20 | 0.58 |
| ▸ | ITGA4 | P13612 | 12/20 | 0.52 |
| ▸ | ITGB7 | P26010 | 4/20 | 0.52 |
| ▸ | ITGB1 | P05556 | 11/20 | 0.52 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Phenylalanine SCHEMBL28033224 | 1.00 | PPARG (0.63) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL7227938 | 0.94 | PPARG (0.63) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL5213839 | 0.94 | PPARG (0.63) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL31398354 | 0.94 | PPARG (0.63) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL22189981 | 0.91 | MAPK1 (0.60) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL22189983 | 0.91 | MAPK1 (0.60) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL22190008 | 0.91 | MAPK1 (0.60) | PPARGPPARAALPIPKMPTGS1 | |
| Dl-Phenylalanine SCHEMBL28020207 | 0.88 | SLC7A5 (0.73) | PPARGPPARAALPIPKMPTGS1 | |
| SCHEMBL7349532 | 0.85 | TPH1 (0.57) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7349516 | 0.85 | TPH1 (0.57) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024129720-A2 | T CELL RECEPTOR CONSTRUCTS AND USES THEREOF | BIONTECH US INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| EP-4121756-A1 | METHOD FOR DETECTING POLYSORBATES | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2023-01-25 | — | — | EP | disclosed |
| EP-3982980-A1 | NEOANTIGEN COMPOSITIONS AND USES THEREOF | BioNTech US Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2021224803-A1 | PEPTIDE INHIBITORS OF SARSR-COV INFECTION | NONO INC. (CA) | 2021-11-11 | — | — | WO | disclosed |
| WO-2021202830-A2 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | TARVEDA THERAPEUTICS, INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021186363-A1 | METHOD FOR DETECTING POLYSORBATES | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2021-09-23 | — | — | WO | disclosed |
| WO-2020252039-A1 | NEOANTIGEN COMPOSITIONS AND USES THEREOF | BIONTECH US INC. (US) | 2020-12-17 | — | — | WO | disclosed |
| US-9913884-B2 | HLA-A2 tumor associated antigen peptides and compositions | OSE PHARMA INTERNATIONAL SA (CH) | 2018-03-13 | — | — | US | disclosed |
| EP-3189152-A1 | DISCOVERING AND PRODUCING CONDITIONALLY ACTIVE BIOLOGIC PROTEINS IN THE SAME EUKARYOTIC CELL PRODUCTION HOSTS | BioAtla LLC (US) | 2017-07-12 | — | — | EP | disclosed |
| US-20170028041-A1 | HLA-A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND COMPOSITIONS | OSE PHARMA INTERNATIONAL SA (CH) | 2017-02-02 | — | — | US | disclosed |
| WO-2002085409-A2 | METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO AN ANTIGEN | CHEMOCENTRYX (US) | 2002-10-31 | — | — | WO | disclosed |
| WO-2002066954-A2 | PDZ DOMAIN INTERACTIONS AND LIPID RAFTS | ARBOR VITA CORPORATION (US) | 2002-08-29 | — | — | WO | disclosed |
| EP-1224290-A1 | DISULFIDE CONJUGATED CELL TOXINS AND METHODS OF MAKING AND USING THEM | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2002-07-24 | — | — | EP | disclosed |
| EP-1165124-A1 | RECOMBINANT NEOSPORA ANTIGENS AND THEIR USES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001080887-A2 | METHODS AND CHEMOKIN COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE | CHEMOCENTRYX, INC. (US) | 2001-11-01 | — | — | WO | disclosed |
| WO-2001080882-A2 | METHODS AND COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE | CHEMOCENTRYX, INC (US) | 2001-11-01 | — | — | WO | disclosed |
| WO-2001031020-A1 | DISULFIDE CONJUGATED CELL TOXINS AND METHODS OF MAKING AND USING THEM | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-05-03 | — | — | WO | disclosed |
| WO-2000057905-A1 | RECOMBINANT NEOSPORA ANTIGENS AND THEIR USES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-10-05 | — | — | WO | disclosed |
| WO-1997000081-A1 | A METHOD FOR INHIBITING BACTEREMIA AND BACTERIAL DISSEMINATION | GOYERT SANNA M (US) | 1997-01-03 | — | — | WO | disclosed |
| WO-1994005695-A9 | POLYPEPTIDES OF G-COUPLED RECEPTOR PROTEINS, AND COMPOSITIONS AND METHODS THEREOF | — | 1994-05-11 | — | — | WO | disclosed |